Dual Biologic or Small Molecule Therapy in Pediatric Inflammatory Bowel Disease: A Single Center Experience
Dual biologic or small molecule therapy may be effective and safe for children with refractory PIBD in China.
Authors
- Jin Zhou (ORCID: https://orcid.org/0000-0002-6829-6149)
- Guo Cheng
- Jie Wu (ORCID: https://orcid.org/0009-0001-1260-4202)
- Guoli Wang (ORCID: https://orcid.org/0009-0009-5038-5184)
Institutions
- Capital Medical University (CN)
- Beijing Children’s Hospital (CN)
Publication Details
- Journal
- Children
- Published
- 2025-01-09
- DOI
- https://doi.org/10.3390/children12010075
- Citations
- 3
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 5.45
Funders
- Beijing Municipal Science and Technology Commission
- Beijing Children's Hospital, Capital Medical University